开发和验证13项简短版本的炎症性肠病自我有效度表
Makoto Tanaka1, Aki Kawakami2, Kayoko Sakagami3
1Graduate School of Health Care Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. hmakoto-tky@umin.ac.jp.
BMC gastroenterology
|May 31, 2024
概括
为了减少患者负担,开发了一种较短的炎症性肠病自我效益量表 (IBD-SES). 这种经过验证的13项尺度保持了原始的心理测量特性,改善了IBD研究中的患者结果.
科学领域:
- 胃肠病学 胃肠病学
- 心理测量 心理测量 心理测量
- 健康 结果 研究 研究 结果
背景情况:
- 炎症性肠病自我效能度表 (IBD-SES) 是一种广泛使用的工具,用于评估炎症性肠病 (IBD) 患者的健康结果.
- 与原来的29项量表相关的长时间响应负担需要开发一个更短,更有效的版本.
研究的目的:
- 开发和验证IBD-SES的大幅缩短版本.
- 为了减少患者的反应负担,同时保持尺度的心理测量完整性.
主要方法:
- 共有919名IBD患者完成了29项IBD-SES的日本版本.
- 缩小规模涉及评估天花板/地板效应,项目相关性和测试-重新测试可靠性.
- 由此产生的13项尺度被评估为构造有效性 (CFA),标准有效性 (皮尔森相关性) 和内部一致性 (克朗巴赫的α).
主要成果:
- 开发了IBD-SES的13项,四个子尺度版本,反映了原始尺度的领域.
- 确认因素分析表明,模型很适合.
- 在短尺度和原始尺度之间观察到高相关性 (0.97-0.98),Cronbach的α系数在子尺度中从0.68到0.86不等.
结论:
- 成功开发了IBD-SES的简短,经过验证的版本.
- 缩写的尺度显示了更好的有效性,可靠性和心理测量特性.
- 这种较短的规模预计将提高IBD研究中的患者参与度和数据收集效率.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
156
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
156
Inflammatory Bowel Disease II: Crohn's Disease
216
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
216
Self-Discrepancy Theory
18.3K
One influential perspective on what motivates people's behavior is detailed in Tory Higgin's self-discrepancy theory (Higgins, 1987). He proposed that people hold disagreeing internal representations of themselves that lead to different emotional states.
18.3K
Irritable Bowel Syndrome I: Introduction
268
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
268
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126


